Venous Thromboembolism Prophylaxis in Surgical Patients [exemplar]

Prophylaxis for deep vein thrombosis (DVT) and pulmonary embolism (PE), together referred to as venous thromboembolism (VTE), must be addressed for every patient going to the operating room. Multiple guidelines are available to assist choosing the correct prophylactic agent for each patient and type of surgery. The American College of Physicians (ACCP) guidelines have been one of the standards for hospitalist for decades but was last updated in 2012¹ and recommendations and suggestions are based on the type of surgery. The American Society of Hematology (ASH), which put forth their first guideline in this field in 2019², took a broader and slightly more universal approach to prevention strategies. The authors of this module bring forth a blended approach of these two guidelines with an emphasis on the newer guideline.

Create Account

Availability

On-Demand

Expires on Mar 17, 2028

Cost

$0.00

Credit Offered

2 CME Credits

2 ABIM-MOC Points

2 Participation Credits

Description
Faculty
Accreditation

Learning Objectives
After completing this course, the learner should be able to:

Recognize the clinical impact of venous thromboembolism (VTE) on surgical patients.
Describe the risk factors that increase the likelihood of developing a VTE and how to risk stratify surgical patients based on these factors.
Formulate the goals of prophylactic intervention programs.
Summarize the VTE prophylaxis regimens for general and abdominopelvic surgery patients.
Summarize the VTE pharmacologic prophylaxis regimens for major orthopedic surgery patients.
Outline when to initiate VTE pharmacologic prophylaxis and the current roles of extended VTE pharmacologic prophylaxis.

Based on the original Venous Thromboembolism Prophylaxis in Surgical Patients, by Charles Locke, MD, Michael Steiff, MD and Leonard Feldman, MD.

If you are a program director and would like to grant access to your trainees, please reach out to education@hospitalmedicine.org for an academic access code.

See other courses in this series: SHM Consults.

Faculty

Shreejith Pillai, MD
Tanya Kakar, MD
Scott Kaatz, DO, MSc, SFHM
- Dr. Kaatz reports consulting for Janssen, BMS-Pfizer, Gilead, CSL Behring, Astra Zeneca, and Portola/Alexicon, Novartis, and has received research grants or contracts from BMS and Janssen
Leonard Feldman, MD, FACP, SFHM
Kurt Pfeifer, MD, FACP, SFHM, DFPM

Faculty Disclosures
The faculty and planners of these activities have no relevant relationships to disclose. All relevant relationships were mitigated prior to the start of this activity.

Conflict of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Statement
The Society of Hospital Medicine designates this online activity for a maximum of 2.00 AMA PRA Category 1 Credit^TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

MOC Credit Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.